Medical marketing services

In Part II, we discuss various aspects of the topical antimicrobial products currently in common use in the medical, food service, and consumer (personal hygiene) markets. The antimicrobial products of primary interest include iodine complexes (aqueous iodophors and tinctures), aqueous formulations and tinctures of chlorhexidine gluconate, triclosan, and parachlorometaxylenol, alcohol formulations, and quaternary ammonium products. Let us review some general aspects of these topical antimicrobials. 

It was this commercial market that made the filling operation at Port Hope necessary. To serve private-sector customers, Eldorado had to offer them radium in a form that they could use. The filling lab prepared radium for its primary medical market by packing it in needles, moulds, or tubes in precise quantities. Gradually Errington developed an extensive line of other radium products to serve a wide variety of customer needs. One example was radium-beryllium sources for well-lo ng in the oil business. Companies servicing the mining sector used this technique to determine if there were oil reserves in the vicinity of a dry drill hole. Radium combined with beryllium in the proper ratio produces millions of neutrons a second. This neutron source could be lowered down... 

The pressure equipment directive was adopted by the European Parliament and the European Council in May 1997. It harmonises the national laws of the 15 Member States of the European Union relating to equipment subject to the pressure risk. That directive is one of the series of technical harmonisation directives such as for machinery, medical devices, simple pressure vessels, gas appliances and so on, which were foreseen by the Communities programme for the elimination of technical barriers to trade. It therefore aims to ensure the free placing on the market and putting into service of the equipment concerned within the European Union and the European Economic Area. At the same time it permits a flexible regulatory environment, allowing European industry to develop new techniques increasing thereby its international competitiveness. 

Forrester estimates that the market for personal medical monitoring will be 34 billion by 2015, rising from 5 billion in 2010. In 2003 they surveyed 12,000 US households in which 84% said they would, if they were ill, pay for services or equipment to help them stay in their home as long as possible. The question of who pays for such services remains a problem, as the same survey identified that only 9% of the consumers sought medical care not covered by their insurance. 

The FDA of the U.S. Department of Health and Human Services (DHHS) administers the regulatory controls for the Food, Drug, and Cosmetic Act of 1906 and the 1976 and 1990 amendments, which provide approval for commercial distribution of safe and effective medical devices. The 1976 amendments directed the FDA to regulate medical devices under control levels that are necessary to ensure safety and effectiveness. In order to achieve this task, the Medical Device Law under the amendments required the FDA to issue regulations placing all medical devices on the market at that time into one of three regulatory classes ... 

Although, MediChem is a biosecurity products manufacturer, its biotechnology-based R D capabilities are worth mentioning here. The attended markets include Medical, Laboratory, Veterinary, and Environmental sectors. Medicinal chemistry services and drug discovery form the basis of the company, though their capabilities might be applied in a broader range of sectors. These capabilities comprise the areas of Proteomics, Combinatorial and Computational Chemistry, Medicinal Chemistry, Enzymes, Process Development, Analytical and Separations Chemistry, Chemical Synthesis and Scale Up. 

In 1975, the first commercial entity was formed to provide multicenter, outpatient clinical trial contracting services in the United States. This was the beginning of the modern Contract Research Organization (CRO) industry. It is now composed of thousands of domesfic and infernafional firms involved in medical producf evaluations in humans. The total annual expense globally for clinical trials and related functions necessary for commercial, governmenf, and academic therapeutic product development is estimated at US 50 billion, of which about US 15 billion is outsourced to the contract services market. 

Niche CROs usually specialize in selected disease areas of clinical research, or may concentrate on market segments, such as medical devices, data management, IT functions, or a myriad of other singular service offerings. Such firms can be very valuable to early stage product development enterprises, such as biotechnology start-ups, which may be focused... 

Almost all authors see innovations in products and services as a central mechanism for growth. The case chapters all discussed the need for innovative products as central to market share and revenue growth, and several identified the opportunity to extend their customer offerings from core products to new product categories as well as to services. At Siemens Medical Solutions, this included the development of... 

Provide the medical input to the servicing and support of marketed products throughout their life cycle. 

The pharmaceutical physician provides a medical direction to marketing strategy and ensures that product literature and promotional material are legal and factually accurate. This is an important contribution to the medical department s role as medical conscience, as discussed in Section 10.2. Medical input remains necessary to the servicing and support of marketed products throughout their life cycle. 

Companies must have a scientific service to compile and collate all information, whether received from medical representatives or from any other source, about the medicines which they market. 

---